Synopsys: The Upgrade Hinges on an Unproven Reacceleration — September 30 Is the Test

Synopsys fell about a quarter from its one-year high before this week, and that is the part of the story Wells Fargo is betting on. On Thursday the firm's Joe Quatrochi upgraded the chip-design software leader to Overweight from Equal Weight and lifted the price target to $475 from $450, arguing that AI demand momentum is improving and that results can re-accelerate into fiscal 2027. The stock edged higher on the news. For anyone tempted to "buy the dip," the upgrade is a reminder of the real question underneath it: has the 25% slide reset the valuation faster than the business has deteriorated, or is the apparent cheapness partly an accounting artifact?

The 42% growth has an asterisk

Start with what Synopsys sells. Its design-automation software is the tooling nearly every chip company uses to lay out and verify silicon; its design-IP business licenses reusable building blocks for those chips. In its fiscal third quarter, reported revenue rose 42.4% year over year to $2.477 billion, with non-GAAP EPS of $3.91 beating the roughly $3.67 analysts expected. Management raised full-year guidance on "continued AI-driven demand strength" to $9.715 billion of revenue at the midpoint.

But that growth number is not what it looks like. Synopsys completed its roughly $35 billion acquisition of Ansys in mid-2025, and the $2.98 billion of Ansys revenue expected in the current fiscal year is about 31% of the guided $9.7 billion total. The 42% jump is measured against a year-earlier quarter with no Ansys in it. Peel the merger out and the organic EDA business still grew — management cites double-digit EDA growth and a Design IP business that returned to year-over-year growth — but the tidy headline "42% growth at only ~8x sales" is partly a comparison artifact. The price-to-sales multiple is likewise flattered by a now much larger revenue base.

This matters because the upgrade rests on an acceleration claim, and acceleration is precisely what an acquisition obscures. The bull case is not that Synopsys grew 42% last quarter; it is that the underlying growth trends higher into fiscal 2027.

Why the stock already reset

The other half of the setup is valuation. Synopsys trades around $397, down roughly 15% on the year and more than 25% below its $539 one-year high. Even after last quarter's beat and raised guidance, investors have cooled on the name. At about 59 times forward earnings and 31x trailing EV/EBITDA, the stock is no longer a rounded-up AI story — though it still trades meaningfully cheaper than rival Cadence on both price-to-sales (about 8x versus roughly 13x) and EV/EBITDA (32x versus 38x).

The genuine demand is not in dispute. Nvidia disclosed a $2 billion stake in Synopsys last December as part of a partnership to speed up chip-design and engineering simulation with GPUs, and the AI custom-silicon wave brings real bookings, not just a pitch. The skeptics' strongest fact is different: it is that reported growth is merger-inflated and the company's newest customer concentration and balance sheet look nothing like the old, nearly debt-free Synopsys. Gross debt sits near $16.6 billion, net of the Ansys financing, even with $2.6 billion of free cash flow to service it.

The September 30 test

Which is exactly why the upgrade is a catalyst bet as much as a valuation view. Wells Fargo expects the September 30 analyst day to lay out fiscal 2027 guidance "slightly above" Street estimates — in other words, the firm is paying up now on the expectation that management confirms the reacceleration in a little over two weeks. Morgan Stanley also moved to a more constructive stance on the stock earlier this month. That analyst day is the falsification point for the entire "improving momentum" thesis: an in-line or conservative 2027 guide would undercut the re-rate the upgrade is premised on, while a clearly above-street number would validate the reset.

On the evidence as it stands, this looks more like "too early to ignore, but not yet proven" than a clean upgrade to chase. The valuation has absorbed a real share of the bad news, and AI design demand is real — but the reported growth that makes the stock look cheap is inflated by the Ansys merger, and the reacceleration that would justify the multiple is a claim scheduled for confirmation on September 30, not a result already reported. A buyer today is paying forward earnings for a reacceleration that has not yet been put in writing. The honest position is to wait for the analyst day to see whether the growth story — not the merger arithmetic — actually supports the price.